Isomorphic Labs Raises $2.1B for AI Drug Discovery
LONDON, May 12, 2026 Isomorphic Labs has secured a massive $2.1 billion Series B funding round to accelerate the...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
LONDON, May 12, 2026 Isomorphic Labs has secured a massive $2.1 billion Series B funding round to accelerate the...
Las Vegas, Nevada, USA – April 22, 2026 In a landmark move shaping the future of digital transformation in...
Rockville, Maryland, U.S. | April 15, 2026 Leadiant Biosciences has announced a major regulatory milestone with Health Canada approval...
San Diego, U.S. | April 15, 2026 ARS Pharmaceuticals has achieved a major regulatory milestone with Health Canada approval...
Hong Kong | March 30, 2026 Strategic AI Collaboration to Accelerate Drug Discovery Insilico Medicine has announced a major...
RANCHO CORDOVA, California, USA | March 24, 2026 In a significant move to advance sustainable pharmaceutical manufacturing, SK pharmteco...
WARREN, New Jersey, March 13, 2026 Biotechnology innovator Tevogen Bio Holdings Inc. has announced significant advancements in its Tevogen.AI...
March 05, 2026 — South San Francisco, California, USA Global life sciences leader Thermo Fisher Scientific has announced the...
VANCOUVER, CANADA | January 22, 2026 — LIR Life Sciences has announced the completion of the study design for...
